Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products > Novel inhibitors

7,12-Dimethylbenz[a]anthracene (DMBA)

  Cat. No.:  DC47318   Featured
Chemical Structure
57-97-6
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
Get Quotation Now
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
7,12-Dimethylbenz[a]anthracene (DMBA) is an immunosuppressor as well as a potent organ-specific carcinogen.
Chemicals PropertiesBiological activity COA & MSDSRelated productsDatasheet
Cas No.: 57-97-6
Chemical Name: DMBA
Synonyms: Benz[a]anthracene,7,12-dimethyl-;7,12-Dimethylbenz[a]anthracene;7,12-Dimethylbenz(a)anthracene Solution;7,12-Dimethylbenz[a]anthracene solution;7,12-dimethylbenzo[a]anthracene;9,10-Dimethyl-1,2-benzanthracene;Method 8270B - PAH Mix;7,12-Dimethylbenz(a)anthracene;7,12-Dimethylbenz[a]anthracene200µg;DMBA;7,12-Dimethylbenzanthracene;7,12-dimethyltetraphene;7,12-DMBA;7,12-Dimethylbenzanthrancene;6,7-Dimethyl-1,2-benzanthracene;7,12-Dimethyl-1,2-benzanthracene;1,4-Dimethyl-2,3-benzphenanthrene;9,10-Dimethylbenz(a)anthracene;9,10-Dimethyl-1,2-benzanthrazen;7,12-Dimethyl-1:2-benz(a)anthracene;Benz(a)anthracene, 7,12-dimethyl-;Benz[a]anthracene, 7,12-di;Dimethylbenz[a]anthracene;CAS-57-97-6;7,12-Dimethylbenz(a)ant racene;7,12 Dimethylbenzanthracene;9,10-Dimethylbenz[a]anthracene;MLS001333155;9,2-benzanthracene;DMBZA;NCGC00254337-01;7,12-Dimethylbenz[a]anthracene, analytical standard;NS00008928;DMBA/TPA/BPO/MNNG;7,12-Dimethylbenzo[a]anthracene;NCGC00091518-04;CCRIS 274;7,12-Dimethylbenzo(a)anthracene;Benz[a]anthracene, 7,12-dimethyl-;9,10-DIMETHYL-1,2-BENZANTHRACENE [MI];MLS001333156;7,12-Dimethyl-benzo[a]anthracene;1,3-benzphenanthrene;HSDB 2938;HMS2232O09;MFCD00003600;7,12-DIMETHYLBENZ(A)ANTHRACENE;57-97-6;RCRA waste number U094;CHEBI:254496;NCGC00091518-02;WLN: L D6 B666J C1 J1;SMR000857253;Benz[a]anthracene,10-dimethyl-;T71090;FT-0621327;UNII-F05B6S0395;AKOS015903190;CS-W012561;BRN 1912135;NCGC00091518-05;7,12-dimethyl-benzo[b]phenanthrene;NCGC00091518-07;DTXCID70510;Tox21_201805;NCGC00091518-03;712-Dimethyl-benzo[a]anthracene;Dimethylbenzanthrene;NCI-C03918;EINECS 200-359-5;BS-43984;9,10-Dimethyl-1,2-benzanthrazen [German];Q187487;9,2-benzanthrazen;HY-W011845;NCGC00259354-01;7,12-Dimethylbenz (a) ant racene;WLN: L D6 B666J F1 G1;C19488;7,12-Dimethylbenz[a]anthracene, >=98%;AI3-50460;CHEMBL329673;7,12-Dimethylbenz[a]anthracene, >=95%;Tox21_300500;F05B6S0395;6,2-benzanthracene;NSC-408823;RCRA waste no. U094;DTXSID1020510;D0677;NCGC00091518-06;Epitope ID:119712;NSC 408823;NCGC00091518-01;4-05-00-02587 (Beilstein Handbook Reference);MLS002454381;NSC408823;7,2-benzanthracene
SMILES: C12C3=C([H])C([H])=C([H])C([H])=C3C([H])=C([H])C1=C(C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1C=2C([H])([H])[H]
Formula: C20H16
M.Wt: 256.3410
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
Cat. No. Product name Field of application
DC31074 Isopropyl myristate Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868 AZ14133346 AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865 TI17 ​​TI17​​ represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816 Nisoxetine Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641 GENZ-644282 TFA salt Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325 PSMA-617 TFA PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202 Fosaprepitant free acid Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748 O4I4 O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684 ZH8667 ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646 EB-PSMA-617 EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.
X
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Site Map|Privacy PolicyCopyright © 2018-2020 All Rights Reserved. Technical Support:KuuJia